These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 21477587)
1. Transcriptional and epigenetic networks in haematological malignancy. Cheung N; So CW FEBS Lett; 2011 Jul; 585(13):2100-11. PubMed ID: 21477587 [TBL] [Abstract][Full Text] [Related]
2. Epigenetic connections between autoimmune disorders and haematological malignancies. Javierre BM; Esteller M; Ballestar E Trends Immunol; 2008 Dec; 29(12):616-23. PubMed ID: 18951845 [TBL] [Abstract][Full Text] [Related]
3. Epigenetic inactivation of the miR-124-1 in haematological malignancies. Wong KY; So CC; Loong F; Chung LP; Lam WW; Liang R; Li GK; Jin DY; Chim CS PLoS One; 2011 Apr; 6(4):e19027. PubMed ID: 21544199 [TBL] [Abstract][Full Text] [Related]
4. Transcriptional regulation by DNA methylation. Poetsch AR; Plass C Cancer Treat Rev; 2011; 37 Suppl 1():S8-12. PubMed ID: 21601364 [TBL] [Abstract][Full Text] [Related]
5. EHA scientific workshop report: the role of epigenetics in hematological malignancies. Jost E; Galm O Epigenetics; 2007; 2(2):71-9. PubMed ID: 17965605 [TBL] [Abstract][Full Text] [Related]
6. miR-29s: a family of epi-miRNAs with therapeutic implications in hematologic malignancies. Amodio N; Rossi M; Raimondi L; Pitari MR; Botta C; Tagliaferri P; Tassone P Oncotarget; 2015 May; 6(15):12837-61. PubMed ID: 25968566 [TBL] [Abstract][Full Text] [Related]
7. Epigenetic alterations in hematopoietic malignancies. Chung YR; Schatoff E; Abdel-Wahab O Int J Hematol; 2012 Oct; 96(4):413-27. PubMed ID: 23015417 [TBL] [Abstract][Full Text] [Related]